Varda series D brings $251M for space-based drug production
Varda series D brings $251M for space-based drug production
Microgravity-enabled life sciences company that designs and flies uncrewed spacecraft to manufacture pharmaceuticals in orbit, aiming to produce medicines that are difficult or impossible to make on Earth.
None announced
Varda series D brings $251M for space-based drug production
Co-founder and Chief Executive Officer
Co-founder